The yeast infection diagnostics market size is projected to be worth USD 417.7 Million in 2023. The market is likely to surpass USD 711.4 Million by 2033 at a CAGR of 5.5% during the forecast period. Growing yeast infection incidences is aiding the market growth. When the vagina is infected with Candida, it is referred to as a yeast infection.
Candida is a kind of yeast. Candidiasis is most typically seen as a secondary illness in immunocompromised people. These are frequent dwellers in the mouth cavity, gastrointestinal tract, vagina, penis, and other areas. They only become pathogenic when favorable conditions exist.
It can affect the mouth, vagina, penis, and other areas of the body. Antibiotic use is frequently linked to candidiasis. Cancer cytotoxic treatment can produce Candida albicans fungemia, which develops from fungal translocation across damaged mucosal barriers.
Candidiasis is more common in old age and infants, according to NIH: StatPearls 2023. Yeast infection affects around 37% of newly born newborns in the United States.
Other Drivers Propelling the Demand for Yeast Infection Diagnostics Market include:
Challenges for Companies /Manufacturers in the Yeast Infection Diagnostics Market:
Opportunities in the Yeast Infection Diagnostics Market Industry:
Latest Trends in the Yeast Infection Diagnostics Market:
Attributes | Details |
---|---|
Yeast Infection Diagnostics Market Size (2023) | USD 417.7 Million |
Yeast Infection Diagnostics Market Projected Size (2033) | USD 711.4 Million |
Value CAGR (2023 to 2033) | 5.5% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
From 2012 to 2022, the global yeast infection diagnostics market experienced a CAGR of 4.4%, reaching a market size of USD 417.7 Million in 2023.
From 2012 to 2022, the global yeast infection diagnostics market industry witnessed steady growth due to the increased prevalence of yeast infection. According to COVID-19, fungal infections can cause serious disease and death.
COVID-19 with a fungal infection can coexist in some people. COVID-19 therapies, such as steroids and other medicines, can reduce the body's ability to fight fungus.
The creation of diagnostic kits has been facilitated by advances in genomic research and understanding of the genetic underpinnings of yeast specific biomarker.
Future Forecast for Yeast Infection Diagnostics Market Industry:
Looking ahead, the global Yeast Infection Diagnostics Market industry is expected to rise at a CAGR of 5.5% from 2023 to 2033. During the forecast period, the market size is expected to reach USD 711.4 Million by 2033.
The yeast infection diagnostics market industry is expected to continue its growth trajectory from 2023 to 2033. Next generation sequencing has made diagnosis of causal species easy, with intervention of other detection techniques and artificial intelligence. Diagnosis process is prone to become easy, rapid and in small point-of-care testing.
Early identification and diagnosis of yeast infection improves patient health outcomes significantly. Yeast infection diagnostics offer the ability to detect infection and type of causal agent in early-stage of infection, allowing for earlier intervention and better survival rates. The emphasis on early diagnosis is anticipated to drive future demand for yeast infection diagnostic market.
Country | The United States |
---|---|
Market Size (USD Million) by End of Forecast Period (2033) | USD 204.9 Million |
CAGR % 2023 to End of Forecast (2033) | 4.5% |
The Yeast Infection Diagnostics Market industry in the United States is expected to reach a market size of USD 204.9 Million by 2033, expanding at a CAGR of 4.5%. Vaginal candidiasis is the most prevalent among all the yeast infections, according to the Centers for Disease Control and Prevention 2022.
It is considered to be the second most prevalent kind of vaginal infection in the USA, following bacterial vaginal infections. Annually, around 1.4 million outpatient consultations for vaginal candidiasis are made.
Country | The United Kingdom |
---|---|
Market Size (USD Million) by End of Forecast Period (2033) | USD 51.6 million |
CAGR % 2023 to End of Forecast (2033) | 3.7% |
The yeast infection diagnostics market industry in the United Kingdom is expected to reach a market value of USD 51.6 Million, expanding at a CAGR of 3.7% during the forecast period. According to the 2013 Health Technology Assessment, Candida albicans represented 61% of all Invasive fungal disease.
According to an article provided by Public Health England 2021, the overall incidence of Candidaemia in England was 3.5 every 100,000 inhabitants in 2020, a modest rise from 2019 (3.1 per 100,000), with older people having the most severe prevalence of Candidaemia.
The rise in frequency between 2019 to 2020 might be attributed to a significant rise in the number of patients referred to intensive care units (ICUs) in the year 2020 as an outcome of the COVID-19 pandemic.
Patients in ICUs are more likely to develop Candidaemia because the environment permits the opportunistic pathogen to grow invasive, and multiple risk factors underlying Candidaemia overlap with features of ICU patients. The present epidemiologic demographics of IFD in UK critical care units is described in the aforementioned paragraph.
Country | China |
---|---|
Market Size (USD Million) by End of Forecast Period (2033) | USD 64.8 million |
CAGR % 2023 to End of Forecast (2033) | 6.8% |
The yeast infection diagnostics market industry in China is anticipated to reach a market size of USD 64.8 million, moving at a CAGR of 6.8% during the forecast period.
The yeast infection diagnostics market industry in China is expected to grow prominently due to the increasing commercial intervention in production of rapid diagnostic kits and real time PCR kits. As per The Lancet Infectious Diseases today 2018, Chinese, women are the world’s most numerous sufferers of thrush at 29.1 million.
Country | Japan |
---|---|
Market Size (USD Million) by End of Forecast Period (2033) | USD 48.2 million |
CAGR % 2023 to End of Forecast (2033) | 6.4% |
The yeast infection diagnostics market industry in Japan is estimated to reach a market size of USD 48.2 million by 2033, thriving at a CAGR of 6.4%. When pre-reproductive and reproductive population are nearly comparable in quantity or proportion, and post-reproductive population have very few, bell-shaped age pyramids arise.
Japanese demography reflects a curve with a bell shape, indicating that Japan has a larger elderly population. According to Geriatrics (Basel) 2020, there is an elevated prevalence of oral Candidiasis diagnosis in reliant Japanese elderly people.
When contrasted with independent older adults, dependent seniors might be more prone to oral Candida albicans infection. As a result, Japan has emerged as a key market for yeast infection diagnostics.
Country | South Korea |
---|---|
Market Size (USD Million) by End of Forecast Period (2033) | USD 5.1 Million |
CAGR % 2023 to End of Forecast (2033) | 8.2% |
The yeast infection diagnostics market industry in South Korea is expected to reach a market size of USD 5.1 million, expanding at a CAGR of 8.2% during the forecast period. South Korea is well-known for its technology breakthroughs and healthcare innovation.
The country's strong emphasis on research and development, along with a favorable regulatory framework, leads to the growth of the yeast infection diagnostics market by allowing the development and commercialization of improved diagnostic technologies.
The test strips are predominant in yeast infection diagnostics market industry with a market share of 60.2% in 2022. Antifungal susceptibility testing (AFST) is currently frequently utilized and recommended in the treatment of patients suffering from persistent fungal infections like candidiasis and aspergillosis.
The average vaginal pH ranges from 3.8 to 5.0. During a vaginal infection, the pH rises to 5.0-5.5 or 6.0-7.5, and vulvovaginal candidiasis is responsible for 20% to 25% of all vaginitis cases. The test strip is used to detect changes in vaginal pH; it is a tiny, paper-like strip that is put into the vagina for a few seconds before being compared to a color chart to ascertain the pH level.
The vaginal pH Test constitutes 61.9% market share globally in 2022. Vaginal pH strip is more prominently used as it is easy to use by the patients. The strip is cost effective with comparison to the other diagnostic kits. It is more convenient and non-invasive method for initial screening of yeast infection.
The Hospitals are dominating the yeast infection diagnostics market with the market share of 39.2% in 2022. A hospital is able to cut expenses by offering a complete range of services to patients.
Doctors can utilize a variety of diagnostic tests to determine the source of a patient's symptoms. A commitment to provide high-quality care at a reasonable cost. A hospital can assist in identifying potential issues early on, before they become more serious. It enables rapid intervention and therapy, which improves the results for patients.
The market for yeast infection diagnostics is very competitive, with numerous businesses vying for market supremacy. In order to remain a step ahead of the competition in a scenario like this, major players have to implement smart strategies.
Key Strategies Used by the Participants
Product Innovation
Key players focus on developing and introducing innovative products to address unmet needs in the market. They invest in research and development to improve existing formulations, delivery systems, and enhance the efficacy and safety of the products
Strategic Partnerships and Collaborations
Key players often form strategic partnerships and collaborations with other companies, research institutes, or healthcare organizations, these partnerships allow for knowledge sharing, joint research and development efforts, and access to complementary technologies or expertise.
Expansion into Emerging Markets
Key players strive to expand their presence in different geographic regions to tap into new markets and reach a wider customer base. They may establish subsidiaries, distribution networks. Or strategic alliances in various countries to strengthen their market position.
Mergers and Acquisitions
Companies in the market may engage in mergers or acquisitions to consolidate their product portfolio, acquire new technologies, these strategic moves allow companies to enter new market segments, gain access to novel products or intellectual property, and achieve synergies in terms of research, manufacturing, or distributions.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Key Developments in the Yeast Infection Diagnostics Market:
An increase in technological advancements drives the demand.
The rapid and reliable detection of a small number of infectious agents drives sales.
The market expands at a CAGR of 5.5% from 2023 to 2033.
The increase in commercial intervention in the production of rapid diagnostic kits raises the demand in China.
China is likely to expand at a CAGR of 6.8% from 2023 to 2033.
Explore Healthcare Insights
View Reports